Inclusion Criteria:

1. Patients 18 years or above at the time of inclusion;

2. Patients newly diagnosed with acute myeloid leukemia;

3. No contraindication or intolerance to any of the components of the standard
chemotherapy by induction (7+3);

4. Patients able to give written informed consent.

Exclusion Criteria:

1. Patients unable to tolerate decubitus position for at least 45 minutes;

2. Any previous neoplasia or other neoplasia simultaneously;

3. Previously treated buy radiotherapy, with bone marrow in the field of radiation;

4. Other chemotherapy treatment than the standard chemotherapy by induction (7+3),
before the second FLT-TEP was done.